uniQure (QURE) EBT Margin Growth (1y) (2017 - 2026)
uniQure (QURE) EBT Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
uniQure |
2.88 Bn |
2.88 Bn |
3.34 Mn |
126,385.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
126,385.00 |
| Dec 31, 2025 |
56,965.00 |
| Sep 30, 2025 |
-100.00 |
| Jun 30, 2025 |
-21,125.00 |
| Mar 31, 2025 |
-198,749.00 |
| Dec 31, 2024 |
8,126.00 |
| Sep 30, 2024 |
442,920.00 |
| Jun 30, 2024 |
232,295.00 |
| Mar 31, 2024 |
70,733.00 |
| Dec 31, 2023 |
-105,549.00 |
| Sep 30, 2023 |
-304,554.00 |
| Jun 30, 2023 |
510,290.00 |
| Mar 31, 2023 |
116,624.00 |
| Dec 31, 2022 |
-721.00 |
| Sep 30, 2022 |
-149,329.00 |
| Jun 30, 2022 |
-801,016.00 |
| Mar 31, 2022 |
646,721.00 |
| Dec 31, 2021 |
6,385.00 |
| Sep 30, 2021 |
117,369.00 |
| Jun 30, 2021 |
285,887.00 |
